111
Participants
Start Date
February 20, 2019
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Afabicin
Administered intravenously and orally.
Standard of Care
Administered with SOC in accordance with local practice and applicable treatment guidelines.
Worthwhile Clinical Trials, Lakeview Hospital, Benoni
West Georgia Medical Center LLC, Kutaisi
Vinnytsya Regional Clinical Hospital, Vinnytsia
Dnipropetrovsk Regional Clinical Hospital, Dnipro
Kharkiv Regional Clinical Traumatology Hospital, Kharkiv
City Hospital #9 under Zaporizhia City Council, Zaporizhia
Regional Clinical Hospital under Ivano-Frankivsk Regional Council, Ivano-Frankivsk
Lviv Regional Hospital of Veterans of Wars and Repressed after Yurii Lypa, Vynnyky
Georgian Clinics JSC, Akhalts'ikhe
Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LLC, Tbilisi
LEPL The First University Clinic of Tbilisi State Medical University, Tbilisi
Tbilisi State Medical University And Ingorokva High Medical Technology University Clinic LLC, Tbilisi
Academician Vakhtang Bochorishvili Clinic LTD, Tbilisi
Caucasus Medical Center LLC, Tbilisi
Clinical Research Unit, University of Pretoria, Pretoria
Global Clinical Trials (Pty) Ltd, Pretoria
Institute of Traumatology and Orthopedics, Kyiv
Kyiv Regional Clinical Hospital, Kyiv
Kyiv City Clinical Hospital #8 under the Executive Body of Kyiv City Council (Kyiv City State Administration), Kyiv
Lead Sponsor
Debiopharm International SA
INDUSTRY